SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dil board to consider final dividend

16 May 2017 Evaluate

Dil has informed that the meeting(s) of the Audit Committee and Board of Directors of the Company are scheduled to be held on May 30, 2017, to consider and approve Audited financial statements (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2017 and recommend final equity dividend, if any, for the financial year 2016-17. Further, in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, it is hereby notified that ‘Trading Window’ (period for trading in Company’s securities) shall remain closed from May 13, 2017 till the close of business hours on June 01, 2017, for approval of the Audited financial results (Standalone and Consolidated) of the Company, for the quarter and year ended March 31, 2017 along with audited financial results for the fourth quarter (which shall be balancing figure) and recommendation of final dividend, if any for the said financial year. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s Equity Shares, either in their own name or in the name of their Immediate Relatives.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

312.55 -9.30 (-2.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×